Carl Zeiss Meditec AG Reports Decline in Q1 FY 2025/26 Earnings

Carl Zeiss Meditec AG has announced its earnings for the first quarter of fiscal year 2025/26, revealing a significant decline compared to the previous year. The company reported preliminary revenue of €467 million, down from €490 million in the same period last year. Operating profit (EBITA) also fell sharply to €8 million from €35 million.

This downturn is attributed to multiple factors, including adverse currency effects, the prior year's robust equipment deliveries leading to a softer start, and geopolitical uncertainties impacting the investment climate in the Americas. Additionally, the withdrawal of a bifocal intraocular lens from a Chinese procurement tender and delays in Chinese hospital demand further contributed to the decline. Anticipated competitive pressures in Chinese procurement are also expected to impact future revenue.